2型糖尿病患者におけるメトホルミン治療と金属動態の変化との関連
Natsu Otowa-Suematsu1, Kazuhiko Sakaguchi1,2, Tomoko Yamada1
1Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
BMJ open diabetes research & care
|August 31, 2025
まとめ
2型糖尿病患者におけるメトホルミンの使用は,血清の銅と鉄のレベルを著しく低下させ,亜鉛を増加させる. これらの発見は,メトフォーミンが重要な金属動力学に影響を与え,治療効果に影響を与える可能性があることを示唆しています.
科学分野:
- 内分泌学
- 栄養学的生化学
- 薬理学について
背景:
- メトフォーミンの金属ケラ化作用は知られているが,その臨床的関連性は不明である.
- この活動は,抗腫瘍および抗炎症作用などのメトホルミンのプレイオトロプ効果に寄与する可能性があります.
- メタルダイナミクスに対するメトフォーミンの影響を調査するヒトの研究は欠けている.
研究 の 目的:
- 2型糖尿病患者の血清金属濃度に対するメトホルミンの影響を調査する.
- 銅,鉄,亜鉛,ビタミンB12の濃度が変化しているかどうかを判断する.
主な方法:
- 横断的な研究デザイン
- 少なくとも6ヶ月間メトホルミンで治療されたか未治療の2型糖尿病患者の募集
- 主要評価項:血清銅の差;次要評価項:血清鉄,亜鉛,ビタミンB12,および関連パラメータ
主要な成果:
- メトホルミン使用者 (n=93) は血清銅 (16. 0対17. 8μmol/ L) と鉄 (16. 3対17. 3μmol/ L) が使用者でない人 (n=96) に比べて低かった.
- メトホルミンの使用者は血清亜鉛 (13. 3対12. 5μmol/ L) とビタミンB12 (338. 7対412. 8 pmol/ L) を高めた.
- メトホルミンの使用は,血清銅と鉄の濃度の低下を予測する独立した指標であった.
結論:
- 銅と鉄の減少,亜鉛の増加を含む血清金属濃度の大幅な変化と関連しています.
- メタルダイナミクスにおけるこれらの観察された変化は,メトフォーミンの薬理学的作用と関連している可能性があります.
- メトフォーミン誘発の金属乱射の臨床的影響を明らかにするために,さらなる研究が必要である.
関連する概念動画
Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Carbohydrate Metabolism
11.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.7K
Diabetes: Symptoms, Diagnosis, and Complications
685
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
685
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K


